-
EP4037736
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4037736
| EP4037736 - DRUG DELIVERY DEVICE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 08.07.2022 Database last updated on 31.08.2024 | |
| Former | The international publication has been made Status updated on 10.04.2021 | ||
| Former | unknown Status updated on 27.10.2020 | Most recent event Tooltip | 20.09.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 / US | [2022/32] | Inventor(s) | 01 /
FINKELSTEIN, Emil c/o Amgen Inc. One Amgen Center Drive Mail Stop 28-5-A Thousand Oaks, CA 91320-1799 / US | 02 /
SKALL, Soren, Forbech c/o Amgen Inc. One Amgen Center Drive Mail Stop 28-5-A Thousand Oaks, CA 91320-1799 / US | 03 /
EILERTSEN, Lars c/o Amgen Inc. One Amgen Center Drive Mail Stop 28-5-A Thousand Oaks, CA 91320-1799 / US | 04 /
ØHLENSCHLÆGER, Rasmus c/o Amgen Inc. One Amgen Center Drive Mail Stop 28-5-A Thousand Oaks, CA 91320-1799 / US | [2022/32] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [2022/32] | Application number, filing date | 20792903.5 | 29.09.2020 | [2022/32] | WO2020US70591 | Priority number, date | US201962908504P | 30.09.2019 Original published format: US 201962908504 P | [2022/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021067990 | Date: | 08.04.2021 | Language: | EN | [2021/14] | Type: | A1 Application with search report | No.: | EP4037736 | Date: | 10.08.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.04.2021 takes the place of the publication of the European patent application. | [2022/32] | Search report(s) | International search report - published on: | EP | 08.04.2021 | Classification | IPC: | A61M5/28, A61M5/315, A61M5/20, A61M5/32 | [2022/32] | CPC: |
A61M5/2033 (EP,CN,IL,US);
A61M5/31581 (CN,IL,US);
A61M5/31501 (EP,CN,IL);
A61M5/31535 (CN,IL,US);
A61M5/31591 (EP,CN,IL);
A61M5/326 (CN);
A61M2005/2013 (EP,CN,IL);
A61M2005/208 (EP,CN,IL);
A61M2005/31508 (EP,CN,IL);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/32] | Title | German: | ARZNEIMITTELABGABEVORRICHTUNG | [2022/32] | English: | DRUG DELIVERY DEVICE | [2022/32] | French: | DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT | [2022/32] | Entry into regional phase | 17.03.2022 | National basic fee paid | 17.03.2022 | Designation fee(s) paid | 17.03.2022 | Examination fee paid | Examination procedure | 17.03.2022 | Examination requested [2022/32] | 17.03.2022 | Date on which the examining division has become responsible | 17.11.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 21.09.2022 | Renewal fee patent year 03 | 20.09.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2006264830 (HOMMANN EDGAR [CH]) [Y] 75-79* paragraph [0038]; figure 7 *; | [XAY]EP2823838 (SANOFI AVENTIS DEUTSCHLAND [DE]) [X] 1-5,22,74-83,94,95 * the whole document * [A] 6-15,23-30,84-93 [Y] 75-79; | [XAY]WO2018166985 (SANOFI AVENTIS DEUTSCHLAND [DE]) [X] 1-5,22,74-83,94,95 * the whole document * [A] 6-15,23-30,84-93 [Y] 75-79 | by applicant | US7153507 | - CAS, no. 501423-23-0 |